FAUSTINI, Gaia
 Distribuzione geografica
Continente #
NA - Nord America 1.559
EU - Europa 1.413
AS - Asia 576
SA - Sud America 6
OC - Oceania 4
AF - Africa 2
Totale 3.560
Nazione #
US - Stati Uniti d'America 1.548
PL - Polonia 659
IT - Italia 231
CN - Cina 223
UA - Ucraina 158
SG - Singapore 153
DE - Germania 103
FI - Finlandia 72
HK - Hong Kong 67
FR - Francia 41
TR - Turchia 40
IE - Irlanda 39
GB - Regno Unito 38
VN - Vietnam 36
RU - Federazione Russa 34
IN - India 21
ID - Indonesia 16
SE - Svezia 13
CA - Canada 11
CZ - Repubblica Ceca 11
BE - Belgio 8
IR - Iran 4
KR - Corea 4
AU - Australia 3
BR - Brasile 3
IL - Israele 3
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
JP - Giappone 2
LB - Libano 2
AR - Argentina 1
BD - Bangladesh 1
BO - Bolivia 1
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
LA - Repubblica Popolare Democratica del Laos 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
Totale 3.560
Città #
Warsaw 659
Fairfield 201
Singapore 136
Jacksonville 128
Chandler 120
Ashburn 111
Woodbridge 101
Brescia 88
Cambridge 86
Seattle 83
Dearborn 77
Houston 72
Princeton 72
Wilmington 68
Hong Kong 66
Ann Arbor 61
Helsinki 61
Beijing 53
New York 45
Dublin 39
Dong Ket 36
Istanbul 35
Nanjing 33
Milan 26
Boardman 18
Moscow 18
Jakarta 16
Jinan 16
Shanghai 16
Des Moines 13
Pune 13
San Diego 13
San Giuliano Milanese 13
Shenyang 13
Hebei 11
Brno 10
Munich 10
Lappeenranta 9
Changsha 8
Toronto 8
Brussels 7
Cattolica 7
Rome 7
San Donà Di Piave 7
Tianjin 7
Lanzhou 6
Nanchang 6
Pavia 6
Romola 6
San Francisco 6
Taizhou 6
Hangzhou 5
Jiaxing 5
Kunming 5
Oxford 5
San Cesareo 5
Hefei 4
London 4
Los Angeles 4
Napoli 4
Ningbo 4
Providence 4
Zhengzhou 4
Ardabil 3
Augusta 3
Cagliari 3
Fulda 3
Guangzhou 3
Haikou 3
Kafr Manda 3
Kilburn 3
Leawood 3
Norwalk 3
Paris 3
Taiyuan 3
Ulsan 3
Amman 2
Cairo 2
Canberra 2
Manhattan 2
Mineola 2
Ottawa 2
Padova 2
São Paulo 2
Tokyo 2
Trento 2
Verona 2
West Jordan 2
Amstelveen 1
Atlanta 1
Auckland 1
Baotou 1
Blackpool 1
Bocholt 1
Bristol 1
Buenos Aires 1
Camerino 1
Castelfranci 1
Central 1
Chicago 1
Totale 2.861
Nome #
Anionic liposomes for siRNA delivery to primary neuronal cells: evaluation of Alpha synuclein knockdown efficacy 260
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 253
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 229
Living in promiscuity: The multiple partners of alpha-synuclein at the synapse in physiology and pathology 182
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 180
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 158
Alpha-Synuclein Preserves Mitochondrial Fusion and Function in Neuronal Cells 147
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 142
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 128
Mitochondrial Dysregulation and Impaired Autophagy in iPSC-Derived Dopaminergic Neurons of Multiple System Atrophy 125
Synapsin III alterations in Parkinson's disease 113
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 112
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 97
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 93
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 82
Study of alpha-synuclein fibrillation: State of the art and expectations 80
Parkinson's disease: from synaptic loss to connectome dysfunction 79
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 75
Synapsin III knock-out reduces AAV-alpha-synuclein overexpression-related neuropathology in the nigrostriatal system 74
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 72
Synapsin III and Alpha-Synuclein cooperation in the onset of synaptic pathology in Parkinson’s Disease 71
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 70
The good and bad of therapeutic strategies that directly target α-synuclein 70
Design and Synthesis of Fluorescent Methylphenidate Analogues for a FRET-Based Assay of Synapsin III Binding 70
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and nigral cell loss in an AAV-based mouse model of Parkinson’s disease 68
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 62
. Alpha-synuclein is a crucial mediator of mitochondrial fusion and functions 60
Alpha-synuclein absence affected mitochondrial fusion and functions 53
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 53
Synapsin III deficiency hampers α-synuclein aggregation, striatal synaptic damage and synaptic protein’s redistribution 51
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease 44
Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction 43
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 39
The association between α-synuclein and α-tubulin in brain synapses 33
Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype 33
Validation of synapsin III as a therapeutic target for Parkinson’s disease in the AAV-mediated alpha-synuclein mouse model 32
Methylphenidate Analogues as a New Class of Potential Disease-Modifying Agents for Parkinson’s Disease: Evidence from Cell Models and Alpha-Synuclein Transgenic Mice 29
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy? 26
Changes in α-Synuclein Posttranslational Modifications in an AAV-Based Mouse Model of Parkinson's Disease 21
Synapsin III Regulates Dopaminergic Neuron Development in Vertebrates 20
DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease 17
Early α-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease 6
Totale 3.652
Categoria #
all - tutte 17.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020670 0 0 0 0 0 133 105 115 78 127 64 48
2020/2021716 39 59 36 74 58 59 26 76 68 92 65 64
2021/2022339 29 43 23 12 4 28 13 28 19 25 41 74
2022/2023376 50 1 10 30 35 93 3 38 64 10 18 24
2023/2024422 35 8 39 37 20 80 17 16 73 10 14 73
2024/2025303 5 13 19 107 98 61 0 0 0 0 0 0
Totale 3.652